These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1666494)

  • 21. Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs.
    Hanberger H; Nilsson LE; Maller R; Isaksson B
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1710-6. PubMed ID: 1659305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative in vitro activity of LY146032 (daptomycin) against gram-positive cocci.
    Machka K; Braveny I
    Eur J Clin Microbiol; 1987 Feb; 6(1):96-9. PubMed ID: 3032613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Consequences of daptomycin-mediated membrane damage in Staphylococcus aureus.
    Hobbs JK; Miller K; O'Neill AJ; Chopra I
    J Antimicrob Chemother; 2008 Nov; 62(5):1003-8. PubMed ID: 18669516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antistaphylococcal activity of a cyclic peptide, LY146032, and vancomycin.
    Knapp CC; Washington JA
    Antimicrob Agents Chemother; 1986 Dec; 30(6):938-9. PubMed ID: 3028254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro evaluation of the cyclic lipopeptide LY 146032 (daptomycin).
    Botha PL; van Heerden CJ; Vorster E; Venter EC
    S Afr Med J; 1988 Jul; 74(1):16-8. PubMed ID: 2838918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Staphylococcus aureus metabolic adaptations during the transition from a daptomycin susceptibility phenotype to a daptomycin nonsusceptibility phenotype.
    Gaupp R; Lei S; Reed JM; Peisker H; Boyle-Vavra S; Bayer AS; Bischoff M; Herrmann M; Daum RS; Powers R; Somerville GA
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4226-38. PubMed ID: 25963986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase-negative staphylococci strains: a systematic review and meta-analysis.
    Shariati A; Dadashi M; Chegini Z; van Belkum A; Mirzaii M; Khoramrooz SS; Darban-Sarokhalil D
    Antimicrob Resist Infect Control; 2020 Apr; 9(1):56. PubMed ID: 32321574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ex vivo study of serum bactericidal titers and killing rates of daptomycin (LY146032) combined or not combined with amikacin compared with those of vancomycin.
    Van der Auwera P
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1783-90. PubMed ID: 2556079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of LY146032 (daptomycin) against selected aerobic bacteria.
    Jorgensen JH; Maher LA; Redding JS
    Eur J Clin Microbiol; 1987 Feb; 6(1):91-6. PubMed ID: 3032612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of the early killing of Staphylococcus aureus by daptomycin by using an in vitro pharmacodynamic model.
    Vance-Bryan K; Larson TA; Rotschafer JC; Toscano JP
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2334-7. PubMed ID: 1332596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Daptomycin exerts bactericidal activity without lysis of Staphylococcus aureus.
    Cotroneo N; Harris R; Perlmutter N; Beveridge T; Silverman JA
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2223-5. PubMed ID: 18378708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Acyl-Linked Dimer of Daptomycin Is Strongly Inhibited by the Bacterial Cell Wall.
    Taylor RM; Scott B; Taylor S; Palmer M
    ACS Infect Dis; 2017 Jul; 3(7):462-466. PubMed ID: 28350438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Daptomycin-loaded biodegradable thermosensitive hydrogels enhance drug stability and foster bactericidal activity against Staphylococcus aureus.
    Casadidio C; Butini ME; Trampuz A; Di Luca M; Censi R; Di Martino P
    Eur J Pharm Biopharm; 2018 Sep; 130():260-271. PubMed ID: 30064700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus.
    Hayden MK; Rezai K; Hayes RA; Lolans K; Quinn JP; Weinstein RA
    J Clin Microbiol; 2005 Oct; 43(10):5285-7. PubMed ID: 16207998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.
    Tsuji BT; Rybak MJ
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2735-45. PubMed ID: 15980344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative association between electrical potential across the cytoplasmic membrane and early gentamicin uptake and killing in Staphylococcus aureus.
    Eisenberg ES; Mandel LJ; Kaback HR; Miller MH
    J Bacteriol; 1984 Mar; 157(3):863-7. PubMed ID: 6698939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Enterococcus faecalis on the bactericidal activities of arbekacin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus in a mixed-pathogen pharmacodynamic model.
    LaPlante KL; Rybak MJ; Leuthner KD; Chin JN
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1298-303. PubMed ID: 16569844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement of the antibacterial activity of daptomycin-loaded polymeric microparticles by Eudragit RL 100: an assessment by isothermal microcalorimetry.
    Ferreira IS; Bettencourt A; Bétrisey B; Gonçalves LM; Trampuz A; Almeida AJ
    Int J Pharm; 2015 May; 485(1-2):171-82. PubMed ID: 25772414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of simulated serum concentrations of daptomycin versus vancomycin during the first 24h of treatment in the presence of physiological albumin concentrations against vancomycin-susceptible, -tolerant or -intermediate-resistant Staphylococcus aureus.
    Torrico M; Aguilar L; Sevillano D; Giménez MJ; Alou L; González N; Cafini F; Cleeland R; Prieto J
    Int J Antimicrob Agents; 2011 Apr; 37(4):332-8. PubMed ID: 21388792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of human serum on the bactericidal activity of daptomycin and vancomycin against staphylococcal and enterococcal isolates as determined by time-kill kinetic studies.
    Stratton CW; Weeks LS
    Diagn Microbiol Infect Dis; 1990; 13(3):245-52. PubMed ID: 2166634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.